MapLight Therapeutics (MPLT) Earnings Analysis
MapLight Therapeutics (MPLT) next reports earnings on 2026-09-18, consensus EPS -1.32414 USD. Last quarter (2026-06-25) it missed with EPS -1.34 USD vs -0.91 USD est (-47.3%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -7.71.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MPLT next report earnings?
| Next earnings date | 2026-09-18 |
|---|---|
| Consensus EPS estimate | -1.32414 USD |
| Revenue estimate | n/a |
MPLT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-25 | -1.34 USD | -0.91 USD | -47.3% | Miss |
| 2026-05-14 | -1.34 USD | -0.962 USD | -39.3% | Miss |
| 2025-12-04 | -37.18 USD | -1.72 USD | -2061.6% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
MPLT valuation and analyst view
| Trailing P/E | -7.71 |
|---|---|
| Trailing EPS | -4.40579 USD |
| Price / book | 4.00 |
| Dividend yield | 0.00% |
| Market cap | 0.03B |
| Analyst consensus | Buy (5 buy / 0 hold / 0 sell) |
| Avg price target | 44.56 USD |
Related research pages
Frequently asked questions
When is MapLight Therapeutics (MPLT)'s next earnings date?
MapLight Therapeutics is next scheduled to report on 2026-09-18, with a consensus EPS estimate of -1.32414 USD.
Did MPLT beat earnings last quarter?
In its 2026-06-25 report, MPLT posted EPS of -1.34 USD versus a -0.91 USD estimate — a miss of 47.3%.
What is MPLT's earnings track record?
Over the last 3 reported quarters with consensus data, MPLT beat estimates 0 times (0%).
What is MPLT's current P/E ratio and EPS?
MPLT trades at a trailing P/E of -7.71 on trailing EPS of -4.405791995333235 USD.
What do analysts rate MPLT?
Analyst consensus is "Buy" across 5 ratings (0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 44.56 USD.